Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. | 9,176 | reported | 29 May 2026 | tx 56+2,380,438−22,735 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 1,582 | 2.57 USD | |
| 15 May 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 1,369 | 2.97 USD | first after silence |
| 01 Jan 2026 | EXERCISE | Processa Pharmaceuticals, Inc. | 193 | 0.00 USD | |
| 01 Jan 2026 | EXERCISE | Processa Pharmaceuticals, Inc. | 193 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 204,000 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 68,000 | 0.00 USD | deriv |
| 24 Jul 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 1,401,650 | 0.00 USD | deriv |
| 01 Apr 2025 | EXERCISE | Processa Pharmaceuticals, Inc. | 14,482 | — | |
| 01 Apr 2025 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 4,814 | 0.41 USD | |
| 27 Jan 2025 | PURCHASE | Processa Pharmaceuticals, Inc. | 43,500 | 0.80 USD | |
| 10 Jul 2024 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 271 | 1.71 USD | |
| 05 Apr 2024 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 539 | 2.79 USD | |
| 05 Apr 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 1,675 | — | |
| 10 Jul 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 644 | — | |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 339 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 2,035 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 339 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 2,713 | 0.00 USD | deriv |
| 01 Jan 2024 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 539 | 2.79 USD | |
| 01 Jan 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 1,675 | — | |
| 01 Jan 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 1,675 | 0.00 USD | deriv |
| 31 Jan 2024 | PURCHASE | Processa Pharmaceuticals, Inc. | 2,500 | 2.37 USD | first after silence |
| 01 Feb 2024 | PURCHASE | Processa Pharmaceuticals, Inc. | 1,500 | 2.40 USD | |
| 12 Oct 2023 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 5,000 | 0.32 USD | |
| 10 Oct 2023 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 13,700 | 0.21 USD |
2 purchases reported after at least 12 months of silence — most recent on 15 May 2026.